Study to Assess the Efficacy of 12 Versus 24 Weeks of Extended Treatment in HCV-Genotype 2/3 Patients
Clinical trial NCT00803309 · TERMINATED
Trial details
- NCT number
- NCT00803309
- Sponsor
- HepNet Study House, German Liverfoundation
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2013-08-01
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.